vs
Side-by-side financial comparison of ECB Bancorp, Inc. (ECBK) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $9.5M, roughly 2.0× ECB Bancorp, Inc.). ECB Bancorp, Inc. runs the higher net margin — 27.3% vs 14.6%, a 12.7% gap on every dollar of revenue. On growth, ECB Bancorp, Inc. posted the faster year-over-year revenue change (33.8% vs 16.3%). ECB Bancorp, Inc. produced more free cash flow last quarter ($9.0M vs $2.4M). Over the past eight quarters, ECB Bancorp, Inc.'s revenue compounded faster (23.8% CAGR vs 16.7%).
ECB Bancorp, Inc. (MD) is a US-based bank holding company. It offers a full suite of retail and commercial banking products including deposit accounts, consumer loans, commercial financing and wealth management solutions, primarily serving individuals and small-to-mid enterprises across local markets in Maryland.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
ECBK vs ELMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $18.9M |
| Net Profit | $2.6M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | 36.7% | 19.2% |
| Net Margin | 27.3% | 14.6% |
| Revenue YoY | 33.8% | 16.3% |
| Net Profit YoY | 79.5% | 40.3% |
| EPS (diluted) | $0.32 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $18.9M | ||
| Q3 25 | $8.8M | $16.9M | ||
| Q2 25 | $8.0M | $17.4M | ||
| Q1 25 | $6.9M | $15.7M | ||
| Q4 24 | $7.1M | $16.3M | ||
| Q3 24 | $6.6M | $14.7M | ||
| Q2 24 | $6.3M | $14.8M | ||
| Q1 24 | $6.2M | $13.9M |
| Q4 25 | $2.6M | $2.8M | ||
| Q3 25 | $2.4M | $2.1M | ||
| Q2 25 | $1.4M | $2.2M | ||
| Q1 25 | $1.3M | $1.9M | ||
| Q4 24 | $1.4M | $2.0M | ||
| Q3 24 | $1.1M | $1.5M | ||
| Q2 24 | $791.0K | $1.8M | ||
| Q1 24 | $621.0K | $1.5M |
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | 36.7% | 19.2% | ||
| Q3 25 | 37.0% | 15.8% | ||
| Q2 25 | 23.9% | 17.5% | ||
| Q1 25 | 24.9% | 13.6% | ||
| Q4 24 | 27.3% | 15.6% | ||
| Q3 24 | 23.3% | 13.2% | ||
| Q2 24 | 16.9% | 15.7% | ||
| Q1 24 | 13.4% | 13.3% |
| Q4 25 | 27.3% | 14.6% | ||
| Q3 25 | 27.7% | 12.6% | ||
| Q2 25 | 18.0% | 12.7% | ||
| Q1 25 | 18.7% | 12.1% | ||
| Q4 24 | 20.3% | 12.1% | ||
| Q3 24 | 17.2% | 10.0% | ||
| Q2 24 | 12.6% | 12.3% | ||
| Q1 24 | 10.0% | 10.8% |
| Q4 25 | $0.32 | $0.32 | ||
| Q3 25 | $0.29 | $0.25 | ||
| Q2 25 | $0.17 | $0.26 | ||
| Q1 25 | $0.16 | $0.21 | ||
| Q4 24 | $0.18 | $0.22 | ||
| Q3 24 | $0.14 | $0.16 | ||
| Q2 24 | $0.09 | $0.20 | ||
| Q1 24 | $0.07 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $82.8M | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $171.9M | $45.4M |
| Total Assets | $1.6B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.8M | $13.8M | ||
| Q3 25 | $201.9M | $14.1M | ||
| Q2 25 | $191.0M | $15.3M | ||
| Q1 25 | $143.7M | $15.2M | ||
| Q4 24 | $309.4M | $16.2M | ||
| Q3 24 | $114.8M | $13.9M | ||
| Q2 24 | $108.7M | $16.1M | ||
| Q1 24 | $109.8M | $11.7M |
| Q4 25 | $171.9M | $45.4M | ||
| Q3 25 | $169.3M | $44.7M | ||
| Q2 25 | $168.3M | $43.2M | ||
| Q1 25 | $168.6M | $43.9M | ||
| Q4 24 | $168.3M | $43.6M | ||
| Q3 24 | $166.0M | $41.5M | ||
| Q2 24 | $166.5M | $44.5M | ||
| Q1 24 | $165.8M | $42.5M |
| Q4 25 | $1.6B | $54.9M | ||
| Q3 25 | $1.6B | $53.6M | ||
| Q2 25 | $1.5B | $53.8M | ||
| Q1 25 | $1.5B | $52.5M | ||
| Q4 24 | $1.4B | $52.3M | ||
| Q3 24 | $1.4B | $48.9M | ||
| Q2 24 | $1.3B | $52.2M | ||
| Q1 24 | $1.3B | $48.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.2M | $3.0M |
| Free Cash FlowOCF − Capex | $9.0M | $2.4M |
| FCF MarginFCF / Revenue | 94.7% | 12.7% |
| Capex IntensityCapex / Revenue | 2.2% | 3.4% |
| Cash ConversionOCF / Net Profit | 3.55× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $14.2M | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.2M | $3.0M | ||
| Q3 25 | $4.0M | $169.0K | ||
| Q2 25 | $1.9M | $3.9M | ||
| Q1 25 | $-631.0K | $2.1M | ||
| Q4 24 | $6.2M | $3.2M | ||
| Q3 24 | $861.0K | $2.3M | ||
| Q2 24 | $1.4M | $4.5M | ||
| Q1 24 | $-429.0K | $1.4M |
| Q4 25 | $9.0M | $2.4M | ||
| Q3 25 | $4.0M | $-83.0K | ||
| Q2 25 | $1.8M | $3.7M | ||
| Q1 25 | $-649.0K | $1.9M | ||
| Q4 24 | $6.2M | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | $1.3M | $4.5M | ||
| Q1 24 | $-449.0K | $1.3M |
| Q4 25 | 94.7% | 12.7% | ||
| Q3 25 | 44.9% | -0.5% | ||
| Q2 25 | 23.0% | 21.4% | ||
| Q1 25 | -9.4% | 12.2% | ||
| Q4 24 | 86.8% | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | 21.4% | 30.1% | ||
| Q1 24 | -7.2% | 9.1% |
| Q4 25 | 2.2% | 3.4% | ||
| Q3 25 | 0.8% | 1.5% | ||
| Q2 25 | 0.6% | 0.8% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.8% | 1.4% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.6% | 0.1% | ||
| Q1 24 | 0.3% | 0.6% |
| Q4 25 | 3.55× | 1.10× | ||
| Q3 25 | 1.65× | 0.08× | ||
| Q2 25 | 1.32× | 1.75× | ||
| Q1 25 | -0.49× | 1.10× | ||
| Q4 24 | 4.31× | 1.60× | ||
| Q3 24 | 0.76× | 1.57× | ||
| Q2 24 | 1.75× | 2.46× | ||
| Q1 24 | -0.69× | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECBK
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
